Search Results

There are 9822 results for: content related to: Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

  1. Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1044–1055, C. Ma, V. Huang, D. K. Fedorak, K. I. Kroeker, L. A. Dieleman, B. P. Halloran and R. N. Fedorak

    Article first published online : 3 SEP 2014, DOI: 10.1111/apt.12940

  2. Long-term durability of response to adalimumab in Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 4, April 2012, Pages: 685–690, M. Chaparro, J. Panés, V. García, O. Merino, P. Nos, E. Domènech, M. Peñalva, E. García-Planella, M. Esteve, J. Hinojosa, M. Andreu, F. Muñoz, A. Gutiérrez, J.L. Mendoza, J. Barrio, M. Barreiro-de, I. Vera, P. Vilar, J.L. Cabriada, M.A. Montoro, X. Aldeguer, C. Saro and J.P. Gisbert

    Article first published online : 25 MAY 2011, DOI: 10.1002/ibd.21758

  3. You have free access to this content
    Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab

    Journal of Digestive Diseases

    Volume 12, Issue 5, October 2011, Pages: 379–383, Himanshu Dev VERMA, Ellen Janice SCHERL, Vinita Elizabeth JACOB and Brian Paul BOSWORTH

    Article first published online : 29 SEP 2011, DOI: 10.1111/j.1751-2980.2011.00522.x

  4. You have free access to this content
    Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity

    Arthritis & Rheumatism

    Volume 64, Issue 12, December 2012, Pages: 3850–3855, Charlotte L. Krieckaert, Anna Jamnitski, Michael T. Nurmohamed, Piet J. Kostense, Maarten Boers and Gertjan Wolbink

    Article first published online : 28 NOV 2012, DOI: 10.1002/art.34680

  5. You have free access to this content
    Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease – algorithm for practical management

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 1, January 2016, Pages: 30–51, N. S. Ding, A. Hart and P. De Cruz

    Article first published online : 30 OCT 2015, DOI: 10.1111/apt.13445

  6. Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey

    Inflammatory Bowel Diseases

    Volume 17, Issue 7, July 2011, Pages: 1530–1539, Stephan R. Vavricka, Alain M. Schoepfer, Georg Bansky, Janek Binek, Christian Felley, Martin Geyer, Michael Manz, Gerhard Rogler, Philippe de Saussure, Bernhard Sauter, Michael Scharl, Frank Seibold, Alex Straumann, Pierre Michetti and for the Swiss IBDnet

    Article first published online : 22 DEC 2010, DOI: 10.1002/ibd.21521

  7. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Article first published online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  8. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Article first published online : 5 NOV 2015, DOI: 10.1002/art.39448

  9. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  10. Abstracts from the 2008 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's National Clinical & Research Conference

    Inflammatory Bowel Diseases

    Volume 14, Issue S3, December 2008, Pages: S1–S49,

    Article first published online : 26 NOV 2008, DOI: 10.1002/ibd.20829

  11. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  12. You have free access to this content
    Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial

    Arthritis & Rheumatism

    Volume 50, Issue 5, May 2004, Pages: 1400–1411, Edward C. Keystone, Arthur F. Kavanaugh, John T. Sharp, Hyman Tannenbaum, Ye Hua, Leah S. Teoh, Steven A. Fischkoff and Elliot K. Chartash

    Article first published online : 6 MAY 2004, DOI: 10.1002/art.20217

  13. Adalimumab (Humira)

    Handbook of Therapeutic Antibodies

    Hartmut Kupper, Jochen Salfeld, Daniel Tracey, Joachim R. Kalden, Pages: 696–732, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch27

  14. Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey

    Inflammatory Bowel Diseases

    Volume 16, Issue 6, June 2010, Pages: 933–938, Alain M. Schoepfer, Stephan R. Vavricka, Janek Binek, Christian Felley, Martin Geyer, Michael Manz, Gerhard Rogler, Philippe de Saussure, Bernhard Sauter, Frank Seibold, Alex Straumann and Pierre Michetti

    Article first published online : 10 DEC 2009, DOI: 10.1002/ibd.21127

  15. Short-term response to adalimumab in childhood inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 14, Issue 12, December 2008, Pages: 1683–1687, Joshua D. Noe and Marian Pfefferkorn

    Article first published online : 10 JUL 2008, DOI: 10.1002/ibd.20534

  16. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

    British Journal of Dermatology

    Volume 163, Issue 4, October 2010, Pages: 838–846, P.P.M. Van Lümig, L.L.A. Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof and E.M.G.J. De Jong

    Article first published online : 22 JUL 2010, DOI: 10.1111/j.1365-2133.2010.09950.x

  17. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 8, August 2015, Pages: 1576–1581, R. Bissonnette, C. Maari, K. Barber, C.W. Lynde and R. Vender

    Article first published online : 20 JAN 2015, DOI: 10.1111/jdv.12943

  18. You have free access to this content
    Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

    Arthritis & Rheumatism

    Volume 48, Issue 1, January 2003, Pages: 35–45, Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, Charles A. Birbara, Leah A. Teoh, Steven A. Fischkoff and Elliot K. Chartash

    Article first published online : 10 JAN 2003, DOI: 10.1002/art.10697

  19. Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1912–1921, Jason M. Swoger, Edward V. Loftus Jr., William J. Tremaine, William A. Faubion, Darrell S. Pardi, Sunanda V. Kane, Karen A. Hanson, W. Scott Harmsen, Alan R. Zinsmeister and William J. Sandborn

    Article first published online : 1 APR 2010, DOI: 10.1002/ibd.21272

  20. A pilot study of adalimumab in infliximab-allergic patients

    Inflammatory Bowel Diseases

    Volume 10, Issue 4, July 2004, Pages: 333–338, Adrienne Youdim, Eric A. Vasiliauskas, Stephan R. Targan, Konstantinos A. Papadakis, Andrew Ippoliti, Marla C. Dubinsky, Juan Lechago, Jane Paavola, Jaime Loane, Susie K. Lee, Joanne Gaiennie, Katie Smith, Jason Do and Maria T. Abreu

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200407000-00002